当前的血管药理学 SCIE

期刊简介预计审稿时间： 较慢,6-12周

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

《当代血管药理学》发表临床和研究综述/小综述、原创研究文章、信件、辩论、药物临床试验研究和特邀编辑的问题，以更新所有关注血管疾病治疗的人，弥合临床实践与正在进行的研究之间的差距。

血管疾病是西方国家最常见的死亡原因，其发病率在发展中国家呈上升趋势。因此，大量研究旨在建立有效的急性血管事件治疗方法。长期治疗也受到了广泛关注（例如用于缓解症状）。此外，有效的预防，无论是初级还是次级的，都得到了几项具有里程碑意义的试验结果的支持。血管疾病是一个复杂的领域，涉及初级保健医生和执业护士以及几个专业。后者包括心脏病学、血管和心胸外科、普通医学、放射学、临床药理学和神经病学（卒中科）。

《Current Vascular Pharmacology》(当前的血管药理学)编辑部通讯方式为BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。